BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Alharbi OR, Azzam NA, Almalki AS, Almadi MA, Alswat KA, Sadaf N, Aljebreen AM. Clinical epidemiology of ulcerative colitis in Arabs based on the Montréal classification. World J Gastroenterol 2014; 20(46): 17525-17531 [PMID: PMC4265614 DOI: 10.3748/wjg.v20.i46.17525]
URL: https://www.wjgnet.com/1007-9327/full/v20/i46/17525.htm
Number Citing Articles
1
Abdul Hakim Almakadma, Abdelkarim De Vol, Mohamad S. Alabdaljabar, Sarah Aldosari, Ibrahim Muhsen, Omar AlFreihi, Amr Kurdi, Majid Almadi, Fahad Alsohaibani. Complementary and alternative medicine use and its association with medication adherence in inflammatory bowel disease and other gastrointestinal diseasesSaudi Journal of Gastroenterology 2023; 29(4): 233 doi: 10.4103/sjg.sjg_468_22
2
Farzad Alinaghi, Hasan Göcker Tekin, Johan Burisch, Jashin J Wu, Jacob P Thyssen, Alexander Egeberg. Global Prevalence and Bidirectional Association Between Psoriasis and Inflammatory Bowel Disease—A Systematic Review and Meta-analysisJournal of Crohn's and Colitis 2020; 14(3): 351 doi: 10.1093/ecco-jcc/jjz152
3
Mohammad S. Al-Zahrani, Ahmed A. Alhassani, Khalid H. Zawawi. Clinical manifestations of gastrointestinal diseases in the oral cavityThe Saudi Dental Journal 2021; 33(8): 835 doi: 10.1016/j.sdentj.2021.09.017
4
Zahra Momayez Sanat, Homayoon Vahedi, Reza Malekzadeh, Zeinab Fanni. Epidemiologic profile of inflammatory bowel disease in Eastern Mediterranean Region (EMRO) countries: a systematic review and meta-analysisBMC Public Health 2024; 24(1) doi: 10.1186/s12889-024-18816-z
5
Misbahuddin Rafeeq, Hussam Aly Sayed Murad, Hossam Mohammed Abdallah, Ali M. El-Halawany. Protective effect of 6-paradol in acetic acid-induced ulcerative colitis in ratsBMC Complementary Medicine and Therapies 2021; 21(1) doi: 10.1186/s12906-021-03203-7
6
Othman Alharbi, Majid A. Almadi, Nahla Azzam, Abdulrahman M. Aljebreen, Turki AlAmeel, Stefan Schreiber, Mahmoud H. Mosli. Clinical characteristics, natural history, and outcomes of Crohn's-related intra-abdominal collectionsSaudi Journal of Gastroenterology 2021; 27(2): 79 doi: 10.4103/sjg.SJG_89_20
7
Satimai Aniwan, Priscila Santiago, Edward V. Loftus, Sang Hyoung Park. The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countriesUnited European Gastroenterology Journal 2022; 10(10): 1063 doi: 10.1002/ueg2.12350
8
Koroush Ghanadi, Javad Valizadeh, Afshin Hasanvand. Epidemiological and clinical aspects of ulcerative colitis in west of Iran: a cross sectional studySpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-3248-4
9
Nahla Azzam, Othman Alharbi, Mansour Altuwaijri, Yazed Alruthia, Heba Alfarhan, Suliman Alshankiti, Faris Nafisah, Qusay Ajlan, Abdulrahman Aljebreen, Majid Almadi, Mahmoud H. Mosli. The effectiveness of vedolizumab in advanced therapy-experienced ulcerative colitis patients: Real world data from the Inflammatory Bowel Disease of the Middle East (IBD-ME) Registry groupSaudi Journal of Gastroenterology 2025; 31(1): 34 doi: 10.4103/sjg.sjg_249_24
10
Naim Abu-Freha, Nour Ealiwa, Muhammad AbuTailakh, Muhammad Abu-Abed, Sarah Bader, Rachel Tabu, Doron Schwartz. Ethnic Issues and Disparities in Inflammatory Bowel Diseases: What Can We Learn from the Arab Population in Israel?Journal of Personalized Medicine 2023; 13(6): 1008 doi: 10.3390/jpm13061008
11
Yachana Mishra, Vijay Mishra, Alaa A.A. Aljabali, Mohamed El-Tanani, Gowhar A. Naikoo, Nitin Charbe, Sai Raghuveer Chava, Murtaza M. Tambuwala. 3D Printed Personalized Colon-targeted Tablets: A Novel Approach in Ulcerative Colitis ManagementCurrent Drug Delivery 2024; 21(9): 1211 doi: 10.2174/1567201821666230915150544
12
Mansour Altuwaijri, Loai Hakami, Othman Alharbi, Majid Almadi, Suliman Alshankiti, Abdulrahman Aljebreen, Nahla Azzam. The Long-Term Clinical Effectiveness of Ustekinumab in Antitumor Necrosis Factor-Experienced Crohn’s Disease PatientsCureus 2022;  doi: 10.7759/cureus.28536
13
Ala I Sharara, Samir Al Awadhi, Othman Alharbi, Hisham Al Dhahab, Mohamed Mounir, Leonardo Salese, Ena Singh, Nancy Sunna, Nadine Tarcha, Mahmoud Mosli. Epidemiology, disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle EastExpert Review of Gastroenterology & Hepatology 2018; 12(9): 883 doi: 10.1080/17474124.2018.1503052
14
Nahla A. Azzam, Abdulelah Almutairdi, Hajer Y. Almudaiheem, Turki AlAmeel, Shakir A. Bakkari, Othman R. Alharbi, Khalidah A. Alenzi, Maha A. AlMolaiki, Bedor A. Al-Omari, Rayan G. Albarakati, Ahmed H. Al-Jedai, Omar I. Saadah, Majid A. Almadi, Badr Al-Bawardy, Mahmoud H. Mosli. Saudi consensus guidance for the management of inflammatory bowel disease during pregnancySaudi Journal of Gastroenterology 2023;  doi: 10.4103/sjg.sjg_318_23
15
Zahra Momayez Sanat, Homayoon Vahedi, Reza Malekzadeh, Zeinab Fanni. A systematic review and meta-analysis of extra-intestinal manifestation of inflammatory bowel disease in the Eastern Mediterranean Region (EMRO) countriesAnnals of Medicine & Surgery 2024; 86(5): 2892 doi: 10.1097/MS9.0000000000001543
16
Jesús K. Yamamoto-Furusho, Andrea Sarmiento-Aguilar. Joint involvement in Mexican patients with ulcerative colitis: a hospital-based retrospective studyClinical Rheumatology 2018; 37(3): 677 doi: 10.1007/s10067-017-3834-z
17
Othman AlHarbi, Niazy Abu Farsakh, Sameer Al-Awadhi, Talal Al-Taweel, Inas Mikhail, Faisal Batwa, Khalil Bedran, Dilara Balkan, Levent Mert Gunay, Joseph C. Cappelleri, Marco Boeri, Colton Leach, Sara Habjoka, Mahmoud Mosli. Patient Preferences for Ulcerative Colitis Treatment in the Middle East Region: A Discrete-Choice ExperimentGastro Hep Advances 2024; 3(2): 190 doi: 10.1016/j.gastha.2023.10.002
18
Mohammed Hammoudeh, Eman Elsayed, Saad Al-Kaabi, Manik Sharma, Mohamed Elbadri, Prem Chandra, Niveen Abu Nahia, Samer Hammoudeh. Rheumatic manifestations of inflammatory bowel diseases: A study from the Middle EastJournal of International Medical Research 2018; 46(9): 3837 doi: 10.1177/0300060518781404
19
Othman R. AlHarbi, Ahmad Bahammam, Awad H. Olaish, Nahla A. Azzam, Abdulrahman A. Aljebreen, Majid A. Almadi, Suhail A. Alsaleh. Prevalence, severity and associated factors of restless leg syndrome in inflammatory bowel disease patientsSaudi Journal of Gastroenterology 2021; 27(6): 348 doi: 10.4103/sjg.sjg_642_20
20
Ibrahim Masoodi, Ali S. Alshanqeeti, Shameem Ahmad, Essam J. Alyamani, Abed A. Al-Lehibi, Adel N. Qutub, Khalid N. Alsayari, Ahmed O. Alomair. Microbial dysbiosis in inflammatory bowel diseases: results of a metagenomic study in Saudi ArabiaMinerva Gastroenterologica e Dietologica 2019; 65(3) doi: 10.23736/S1121-421X.19.02576-5
21
Yazed AlRuthia, Othman Alharbi, Abdulrahman M. Aljebreen, Nahla A. Azzam, Majid A. Almadi, Ohud H. Bahari, Khalid A. Almalki, Abdulaziz T. Atham, Ahmed S. Alanazi, Maria Saeed, Baraa HajkhderMullaissa, Mohammad Alsenaidy, Bander Balkhi. Drug utilization and cost associated with inflammatory bowel disease management in Saudi ArabiaCost Effectiveness and Resource Allocation 2019; 17(1) doi: 10.1186/s12962-019-0194-3
22
Othman Alharbi, Abdulrahman M. Aljebreen, Nahla A. Azzam, Majid A. Almadi, Maria Saeed, Baraa HajkhderMullaissa, Hassan Asiri, Abdullah Almutairi, Yazed AlRuthia. Predictors of Anti-TNF Therapy Failure among Inflammatory Bowel Disease (IBD) Patients in Saudi Arabia: A Single-Center StudyJournal of Clinical Medicine 2022; 11(14): 4157 doi: 10.3390/jcm11144157
23
Mahmoud Mosli, Sameer Alawadhi, Fuad Hasan, Antoine Abou Rached, Faisal Sanai, Silvio Danese. Incidence, Prevalence, and Clinical Epidemiology of Inflammatory Bowel Disease in the Arab World: A Systematic Review and Meta-AnalysisInflammatory Intestinal Diseases 2021; 6(3): 123 doi: 10.1159/000518003